Biotech Arbutus to Report Second Quarter 2022 Financial Results and Provide Corporate Update July 21, 2022
Biotech Bragar Eagel & Squire, P.C. Is Investigating Enochian, Corcept, Rollins, and the WWE and Encourages Investors to Contact the Firm July 20, 2022
Biotech Arbutus Biopharma Provides Update on the Phase 2A Combination Trial with AB-729 and a Capsid Inhibitor July 20, 2022
Biotech Nabriva Therapeutics to Report Second Quarter 2022 Financial Results and Recent Corporate Highlights on August 3, 2022 July 20, 2022
Biotech Aytu BioPharma Announces Initiation of the AR101 PREVEnt Trial for the Treatment of Vascular Ehlers-Danlos Syndrome July 20, 2022